RBF Capital’s PDL BioPharma, Inc. PDLI Stock Holding History

RBF Capital’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-600,000	Closed	-$1.89M	–	423
2020 Q3	$1.89M	Hold	600,000	–	–	0.19%	114
2020 Q2	$1.75M	Hold	600,000	–	–	0.19%	112
2020 Q1	$1.69M	Hold	600,000	–	–	0.22%	102
2019 Q4	$1.95M	Buy	600,000 +30,677	+5%	+$89.1K	0.19%	112
2019 Q3	$1.23M	Hold	569,323	–	–	0.14%	137
2019 Q2	$1.79M	Hold	569,323	–	–	0.18%	109
2019 Q1	$2.12M	Sell	569,323 -23,090	-4%	-$78K	0.25%	83
2018 Q4	$1.72M	Buy	592,413 +419,323	+242%	+$1.15M	0.22%	89
2018 Q3	$455K	Hold	173,090	–	–	0.05%	248
2018 Q2	$407K	Hold	173,090	–	–	0.05%	249
2018 Q1	$508K	Hold	173,090	–	–	0.06%	222
2017 Q4	$474K	Sell	173,090 -4,355	-2%	-$13.4K	0.05%	229
2017 Q3	$602K	Hold	177,445	–	–	0.08%	187
2017 Q2	$438K	Hold	177,445	–	–	0.06%	217
2017 Q1	$403K	Sell	177,445 -73,976	-29%	-$164K	0.06%	229
2016 Q4	$540K	Sell	251,421 -22,555	-8%	-$62.9K	0.08%	194
2016 Q3	$918K	Hold	273,976	–	–	0.16%	129
2016 Q2	$860K	Hold	273,976	–	–	0.17%	129
2016 Q1	$912K	Hold	273,976	–	–	0.17%	136
2015 Q4	$970K	Buy	+273,976	New	+$1.15M	0.18%	131

Other funds holding PDLI

SPC

Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

RBF Capital's PDLI Position: Q4 2020 in Review

RBF Capital sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 600,000 shares — an estimated $1.89M sold.

RBF Capital first reported a position in PDLI in Q4 2015 and held it in 20 quarters. The position peaked at $2.12M in Q1 2019. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

RBF Capital reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
RBF Capital sold 600,000 PDL BioPharma, Inc. shares in Q4 2020, an estimated $1.89M.
RBF Capital first reported a position in PDL BioPharma, Inc. in Q4 2015 and held it in 20 quarters.
RBF Capital's PDL BioPharma, Inc. position peaked at $2.12M in Q1 2019.
33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on RBF Capital's 13F filing for Q4 2020, filed 11 Feb 2021.